Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
J. Clin. Invest. Yi Chen, et al. 116:1317 doi:10.1172/JCI25308 [Go to this article.]

Table 3
Anti–IL-23p19 therapeutic treatment inhibits EAE relapse